XXII
22nd Century GroupXXII
XXII
About: 22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.
Employees: 64
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
412% more capital invested
Capital invested by funds: $143K [Q2] → $732K (+$589K) [Q3]
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
13.64% more ownership
Funds ownership: 2.32% [Q2] → 15.96% (+13.64%) [Q3]
9% more funds holding
Funds holding: 33 [Q2] → 36 (+3) [Q3]
43% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 7
Research analyst outlook
We haven’t received any recent analyst ratings for XXII.
Financial journalist opinion
Based on 4 articles about XXII published over the past 30 days
Neutral
GlobeNewsWire
1 week ago
FDA Publishes Proposed New Tobacco Product Standard for Nicotine Yield, Citing VLN from 22nd Century as the Only Combustible Cigarette That Complies with the New Standard
New FDA Rule Cites Extensive Research Using 22nd Century Manufactured Products and Specifically Cites 22nd Century VLN Sales Activity
Neutral
GlobeNewsWire
1 week ago
Washington Post Story Featuring 22nd Century VLN Products Highlights Proposed FDA Reduced Nicotine Content Policy Could Initially Benefit An Estimated 13 Million Smokers
VLN Reduced Nicotine Content Cigarettes from 22nd Century Is the Only Authorized Combustible Solution to Support the FDA's War on Smoking
Neutral
GlobeNewsWire
1 week ago
22nd Century Stands Ready to Support the Adoption of FDA Proposed Tobacco Product Standard to Mandate Reduced Nicotine Content in Cigarettes with its VLN Cigarettes
FDA Reduced Nicotine Content Proposal Indicated to Have Completed OMB Review as of January 3, 2025 FDA Spokesperson Indicates Policy Could Be Among Most Impactful Population-Level Actions in the History of U.S. Tobacco Product Regulation MOCKSVILLE, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it stands ready to support the U.S. Food and Drug Administration's proposed tobacco product standard to mandate reduced nicotine content in cigarettes, which is indicated to have cleared review by the U.S. Office of Management and Budget on January 3, 2025.
Neutral
GlobeNewsWire
2 weeks ago
22nd Century Group Signs New, Expanded License and Manufacturing Agreement with Smoker Friendly
Agreement covers 11 existing brands, supports launch 8 additional premium brands with Smoker Friendly retail and dealer locations
Neutral
Newsfile Corp
1 month ago
22nd Century Announces 1-for-135 Reverse Stock Split
Mocksville, North Carolina--(Newsfile Corp. - December 13, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will effect a reverse stock split of its outstanding shares of common stock, par value $0.00001 per share (the "Common Stock"), at a ratio of 1-for-135, to be effective as of December 17, 2024. The reverse stock split is intended for the Company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on Nasdaq.
Neutral
Newsfile Corp
1 month ago
22nd Century Applauds FDA Proposal to Mandate Reduced Nicotine Content in Cigarettes
Recent FDA Action Advances Policy Proposal That Originated During First Trump Administration and Continued to Progress Under Biden Administration Mocksville, North Carolina--(Newsfile Corp. - December 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it applauds action by the U.S. Food and Drug Administration to advance its long-standing proposal mandating a drastic reduction in the amount of nicotine in cigarettes, a cornerstone goal of public health experts seeking to reduce the harms of smoking. "We are excited to see definitive action by the FDA intended to advance its scientifically backed reduced nicotine content mandate for cigarette products, a non-partisan proposal that actually began moving forward during the first Trump administration and continued its progress during the Biden administration," said Larry Firestone, Chief Executive Officer of 22nd Century Group.
Neutral
Newsfile Corp
2 months ago
22nd Century Group Reports Third Quarter 2024 Financial Results
Remains on Path to Cash Positive Operations in Q1 2025 Commencing Growth Strategy Leveraging Both Internal and External Brand Assets Across Multiple Categories Mocksville, North Carolina--(Newsfile Corp. - November 12, 2024) - 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, today announced results for the third quarter ended September 30, 2024, and provided an update on recent business highlights. Third Quarter 2024 Financial Results (compared to Second Quarter 2024, except as noted) All figures reported below reflect continuing operations, excluding discontinued operations related to the sale and exit of the Company's hemp/cannabis business in late 2023.
Neutral
Newsfile Corp
2 months ago
22nd Century Group (XXII) to Announce Third Quarter 2024 Results on November 12, 2024
Mocksville, North Carolina--(Newsfile Corp. - November 7, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine dependence and believes smokers should have a choice about their nicotine consumption, will host a webcast on Wednesday, November 12, 2024, at 8:00 AM ET to discuss its 2024 third quarter results, which are to be reported in a press release at 6:00 AM ET the same day. During the webcast, Larry Firestone, chairman and chief executive officer, and Dan Otto, chief financial officer, will review financial results and discuss progress made in the recent months.
Neutral
Newsfile Corp
3 months ago
22nd Century Group to Present at the LD Micro Main Event XVII on October 30 in Los Angeles
Mocksville, North Carolina--(Newsfile Corp. - October 21, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, today announced that it will be presenting at the LD Micro Main Event XVII investor conference to be held October 28-30, 2024 in Los Angeles. As part of the conference, the Company will conduct a group presentation at 3:30 pm Pacific Time on Wednesday, October 30, 2024.
Positive
Benzinga
3 months ago
Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Charts implemented using Lightweight Charts™